Corcept Therapeutics
CORT
#3248
Rank
S$5.81 B
Marketcap
S$54.62
Share price
1.21%
Change (1 day)
-51.19%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): S$57.43 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are S$0.76 Billion. a decrease over its 2024 earnings that were of S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 S$57.58 M-67.29%
2024 S$0.17 B27.66%
2023 S$0.13 B-4.75%
2022 S$0.14 B-9.51%
2021 S$0.16 B-2.91%
2020 S$0.16 B14.87%
2019 S$0.14 B24.71%
2018 S$0.11 B69.32%
2017 S$67.94 M419.26%
2016 S$13.08 M-395.64%
2015 -S$4.43 Million-87.53%
2014 -S$35.51 Million-33.44%
2013 -S$53.35 Million
2011 -S$41.57 Million17.84%
2010 -S$35.28 Million35.5%
2009 -S$26.04 Million2.84%
2008 -S$25.32 Million60.81%
2007 -S$15.75 Million-52.14%
2006 -S$32.89 Million20.91%
2005 -S$27.21 Million31.87%
2004 -S$20.63 Million60.54%
2003 -S$12.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$43.13 B 74,797.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.02 B 36,402.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.10 B 22,651.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$33.07 B 57,339.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$28.82 B 49,954.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$11.99 B 20,722.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$39.57 M-31.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$35.28 Million-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.62 B 977.04%๐Ÿ‡บ๐Ÿ‡ธ USA